NCT04598295: A trial that was reported late by Beth Israel Deaconess Medical Center
This trial has reported, although it was 601 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04598295 |
|---|---|
| Title | A Randomized, Double Blind, Placebo-controlled Study to Evaluate the Impact of a Multi-strain Synbiotic on Fecal Metagenomic Stability, Gut Barrier Integrity, and Metabolic Output of the Gut Microbiota |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Oct. 20, 2020 |
| Completion date | Oct. 17, 2022 |
| Required reporting date | Oct. 17, 2023, midnight |
| Actual reporting date | June 9, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 601 |